These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 31233865)

  • 1. Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Guo Y; Xu T; Bao C; Liu Z; Fan J; Yang R; Qin S
    Eur J Pharm Sci; 2019 Aug; 136():104966. PubMed ID: 31233865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA).
    Hannoun MH; Hagras M; Kotb A; El-Attar AMM; Abulkhair HS
    Bioorg Chem; 2020 Jan; 94():103364. PubMed ID: 31668461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus.
    Sunduru N; Gupta L; Chauhan K; Mishra NN; Shukla PK; Chauhan PM
    Eur J Med Chem; 2011 Apr; 46(4):1232-44. PubMed ID: 21345548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.
    Wang J; Ansari MF; Zhou CH
    Bioorg Med Chem Lett; 2021 Jun; 41():127995. PubMed ID: 33775834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.
    Ceballos S; Kim C; Ding D; Mobashery S; Chang M; Torres C
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citral, a monoterpenoid aldehyde interacts synergistically with norfloxacin against methicillin resistant Staphylococcus aureus.
    Gupta P; Patel DK; Gupta VK; Pal A; Tandon S; Darokar MP
    Phytomedicine; 2017 Oct; 34():85-96. PubMed ID: 28899514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.
    Verma SK; Verma R; Kumar KSS; Banjare L; Shaik AB; Bhandare RR; Rakesh KP; Rangappa KS
    Eur J Med Chem; 2021 Jul; 219():113442. PubMed ID: 33878562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
    Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
    Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin derivatives with nitrothiophene substituents: Design, synthesis and antibacterial activity against multidrug-resistant S. aureus.
    Wang ZC; Wei B; Pei FN; Yang T; Tang J; Yang S; Yu LF; Yang CG; Yang F
    Eur J Med Chem; 2020 Jul; 198():112352. PubMed ID: 32387838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship for the oxadiazole class of antibiotics.
    Spink E; Ding D; Peng Z; Boudreau MA; Leemans E; Lastochkin E; Song W; Lichtenwalter K; O'Daniel PI; Testero SA; Pi H; Schroeder VA; Wolter WR; Antunes NT; Suckow MA; Vakulenko S; Chang M; Mobashery S
    J Med Chem; 2015 Feb; 58(3):1380-9. PubMed ID: 25590813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates.
    Zuo GY; Yang CX; Han J; Li YQ; Wang GC
    Phytomedicine; 2018 Jan; 39():93-99. PubMed ID: 29433688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
    Zhao LY; Liu HX; Wang L; Xu ZF; Tan HB; Qiu SX
    J Ethnopharmacol; 2019 Jan; 228():50-57. PubMed ID: 30195566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
    Septama AW; Panichayupakaranant P
    Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus.
    Moreira Osório T; Delle Monache F; Domeneghini Chiaradia L; Mascarello A; Regina Stumpf T; Roberto Zanetti C; Bardini Silveira D; Regina Monte Barardi C; de Fatima Albino Smânia E; Viancelli A; Ariel Totaro Garcia L; Augusto Yunes R; José Nunes R; Smânia A
    Bioorg Med Chem Lett; 2012 Jan; 22(1):225-30. PubMed ID: 22169259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review.
    Jiang D; Liu B; Gao T
    Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
    BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.